Moelis announces CEO succession: Ken Moelis to Executive Chairman, Navid Mahmoodzadegan to CEO effective Oct 1
Moelis & Co
Ken Moelis becomes Executive Chairman; Navid Mahmoodzadegan appointed CEO and board member; Jeff Raich named Executive Vice Chairman.
Mahmoodzadegan receives one-time grant of 450,000 Performance Units with vesting tied to share price targets ($86, $115, $144) and 3-5 year time vesting.
Transition is result of long-term planning; Moelis remains actively involved as Executive Chairman advising clients.
Raich continues to lead key business areas as Executive Vice Chairman.
Jeff Raich, Co-Founder and Co-President, has been appointed Executive Vice Chairman of Moelis and will continue to lead key business areas of the Firm.
Navid Mahmoodzadegan, Co-Founder and Co-President, will succeed Mr. Moelis as Chief Executive Officer and will also join the Board of Directors of the Company.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Ken Moelis changed role as Executive Chairman at Moelis & Co.
Action
will become
Role
Executive Chairman
Exact text from the filing
Ken Moelis, who has served as Chief Executive Officer of the Company since the Company’s inception in 2007, will become Executive Chairman.
Jeff Raich was appointed as Executive Vice Chairman at Moelis & Co.
Action
appointed
Role
Executive Vice Chairman
Exact text from the filing
Jeff Raich, Co-Founder and Co-President, has been appointed Executive Vice Chairman of Moelis and will continue to lead key business areas of the Firm.
Navid Mahmoodzadegan was appointed as Chief Executive Officer at Moelis & Co.
Action
appointed
Role
Chief Executive Officer
Exact text from the filing
Navid Mahmoodzadegan, Co-Founder and Co-President, will succeed Mr. Moelis as Chief Executive Officer and will also join the Board of Directors of the Company.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.